Dr. Kimberly Meza has been honored by The American Association for Cancer Research (AACR) with an AACR-Kidney CAN Scholar-in-Training Award. Meza's award is for “Nuvisertib (TP-3654) and Dordaviprone (ONC201) synergize to reduce renal cell carcinoma cell viability. 

Kidney CAN graciously donated funds to recognize outstanding young investigators and to support their attendance at the AACR Annual Meeting 2026, taking place April 17-22, 2026, at the San Diego Convention Center in San Diego, California. The award funds are to be used to defray the cost of travel, subsistence, and registration expenses to attend the AACR Annual Meeting 2026.